These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 22607863)

  • 1. Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease.
    Shah SH; Sun JL; Stevens RD; Bain JR; Muehlbauer MJ; Pieper KS; Haynes C; Hauser ER; Kraus WE; Granger CB; Newgard CB; Califf RM; Newby LK
    Am Heart J; 2012 May; 163(5):844-850.e1. PubMed ID: 22607863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
    Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
    Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics signature improves the prediction of cardiovascular events in elderly subjects.
    Rizza S; Copetti M; Rossi C; Cianfarani MA; Zucchelli M; Luzi A; Pecchioli C; Porzio O; Di Cola G; Urbani A; Pellegrini F; Federici M
    Atherosclerosis; 2014 Feb; 232(2):260-4. PubMed ID: 24468136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure.
    Ivanes F; Susen S; Mouquet F; Pigny P; Cuilleret F; Sautière K; Collet JP; Beygui F; Hennache B; Ennezat PV; Juthier F; Richard F; Dallongeville J; Hillaert MA; Doevendans PA; Jude B; Bertrand M; Montalescot G; Van Belle E
    Eur Heart J; 2012 Jan; 33(2):191-202. PubMed ID: 21719456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple marker approach to risk stratification in patients with stable coronary artery disease.
    Schnabel RB; Schulz A; Messow CM; Lubos E; Wild PS; Zeller T; Sinning CR; Rupprecht HJ; Bickel C; Peetz D; Cambien F; Kempf T; Wollert KC; Benjamin EJ; Lackner KJ; Münzel TF; Tiret L; Vasan RS; Blankenberg S
    Eur Heart J; 2010 Dec; 31(24):3024-31. PubMed ID: 20852293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of diabetes mellitus on long-term survival in systematic off-pump coronary artery bypass surgery.
    Marcheix B; Vanden Eynden F; Demers P; Bouchard D; Cartier R
    Ann Thorac Surg; 2008 Oct; 86(4):1181-8. PubMed ID: 18805157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of diabetes mellitus on the prognostic value of a normal dobutamine stress echocardiogram in patients with intermediate to high cardiovascular risk.
    Low AF; Ng WL; Lim YT; Yeo TC
    Singapore Med J; 2004 Apr; 45(4):161-5. PubMed ID: 15094984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
    Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials).
    Damman P; Holmvang L; Tijssen JG; Lagerqvist B; Clayton TC; Pocock SJ; Windhausen F; Hirsch A; Fox KA; Wallentin L; de Winter RJ
    Am J Cardiol; 2012 Jan; 109(1):6-12. PubMed ID: 21944677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events.
    Shah SH; Bain JR; Muehlbauer MJ; Stevens RD; Crosslin DR; Haynes C; Dungan J; Newby LK; Hauser ER; Ginsburg GS; Newgard CB; Kraus WE
    Circ Cardiovasc Genet; 2010 Apr; 3(2):207-14. PubMed ID: 20173117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of cardiovascular risk scores in a liver transplant population.
    Guckelberger O; Mutzke F; Glanemann M; Neumann UP; Jonas S; Neuhaus R; Neuhaus P; Langrehr JM
    Liver Transpl; 2006 Mar; 12(3):394-401. PubMed ID: 16498651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
    Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
    Nakagawa K; Hirai T; Takashima S; Fukuda N; Ohara K; Sasahara E; Taguchi Y; Dougu N; Nozawa T; Tanaka K; Inoue H
    Am J Cardiol; 2011 Mar; 107(6):912-6. PubMed ID: 21247518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of infarction-related artery occlusion and multivessel disease in postinfarction angina.
    Valenzuela LF; Vázquez R; Fournier JA; Cubero J; Maraví J; Cruz-Fernández JM; Kaski JC
    Int J Cardiol; 2007 Feb; 115(3):381-5. PubMed ID: 16814417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reclassification of cardiovascular risk in patients with normal myocardial perfusion imaging using heart rate response to vasodilator stress.
    Iqbal FM; Al Jaroudi W; Sanam K; Sweeney A; Heo J; Iskandrian AE; Hage FG
    Am J Cardiol; 2013 Jan; 111(2):190-5. PubMed ID: 23111139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of proteinuria as a prognostic marker of mortality and cardiovascular events among patients undergoing percutaneous coronary intervention (data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] trial).
    Mercado N; Brugts JJ; Ix JH; Shlipak MG; Dixon SR; Gersh BJ; Lemos PA; Guarneri M; Teirstein PS; Wijns W; Serruys PW; Boersma E; O'Neill WW
    Am J Cardiol; 2008 Nov; 102(9):1151-5. PubMed ID: 18940282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.
    Petersson U; Ostgren CJ; Brudin L; Nilsson PM
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):536-40. PubMed ID: 19357517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals.
    Becker A; Leber A; Becker C; Knez A
    Am Heart J; 2008 Jan; 155(1):154-60. PubMed ID: 18082507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which white blood cell subtypes predict increased cardiovascular risk?
    Horne BD; Anderson JL; John JM; Weaver A; Bair TL; Jensen KR; Renlund DG; Muhlestein JB;
    J Am Coll Cardiol; 2005 May; 45(10):1638-43. PubMed ID: 15893180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.